Elpri Eka Permadi
ABSTRACT
Atherosclerosis is one of the causes of cardiovascular disease (CVD). The high level of cholesterol which is controlled by 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase plays an essential role in the pathogenesis of atherosclerosis. By inhibiting the activity of HMG-CoA reductase, the biosynthesis of cholesterol may be limited and therefore contribute to the reduction of blood cholesterol. This research aims to identify the hit compounds of HMG-CoA reductase inhibitors from the natural compounds database of West Bali National Park from the Internal PRBBOT BRIN database (Indonesia's natural compounds data base). We conducted a virtual screening workflow using a quantitative structure-activity relationship (QSAR) strategy based on artificial intelligence approach to allow faster screening of HMG-CoA reductase inhibitor from 2608 compounds. Eight classifications and five regressions in machine learning algorithms were applied to build a virtual screening workflow using the 1173 compounds dataset from the ChEMBL database. The classification QSAR model used the Random Forest and Fuzzy Rule algorithm with a tied score of accuracy were 0.972 and the regression QSAR model used the Tree Ensemble algorithm with the R2 pred = 0.88. Virtual screening results identified three hit compounds as HMG-CoA reductase inhibitors from Calophyllum inophyllum L., including Inocalophyllin B, Brasiliensic acid, and Inophylloidic acid. These results indicated the benefit of the machine learning approaches for potential screening compounds as an inhibitor for the HMG-CoA reductase enzyme, and it may be useful to screen various drug candidates for other target diseases.
Supplemental Material
Available for Download
- S. H. Lin, K. J. Huang, C. F. Weng, and D. Shiuan, “Exploration of natural product ingredients as inhibitors of human HMG-CoA reductase through structure-based virtual screening,” Drug Des. Devel. Ther., vol. 9, pp. 3313–3324, 2015, doi: 10.2147/DDDT.S84641.Google Scholar
- M. Son, A. Baek, S. Sakkiah, C. Park, S. John, and K. W. Lee, “Exploration of virtual candidates for human HMG-CoA reductase inhibitors using pharmacophore modeling and molecular dynamics simulations,” PLoS One, vol. 8, no. 12, pp. 1–10, 2013, doi: 10.1371/journal.pone.0083496.Google ScholarCross Ref
- P. R. Hebert, J. M. Gaziano, K. S. Chan, and C. H. Hennekens, “Cholesterol Lowering With Statin Drugs, Risk of Stroke, and Total Mortality,” Surv. Anesthesiol., vol. 278, no. 4, pp. 313–321, 1997, doi: 10.1097/00132586-199806000-00060.Google Scholar
- E. S. Istvan, “Structural mechanism for statin inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase,” Am. Heart J., vol. 144, no. 6 SUPPL., 2002, doi: 10.1067/mhj.2002.130300.Google Scholar
- V. B. Da Silva, C. A. Taft, and C. H. T. P. Silva, “Use of virtual screening, flexible docking, and molecular interaction fields to design novel HMG-CoA reductase inhibitors for the treatment of hypercholesterolemia,” J. Phys. Chem. A, vol. 112, no. 10, pp. 2007–2011, 2008, doi: 10.1021/jp075502e.Google ScholarCross Ref
- W. Gai, Y. L. Zhang, L. Ai, and Y. J. Qiao, “Screening of HMG-CoA Reductase Inhibitors from Composite Salvia Miltiorrhiza Using Autodock,” Chin. J. Nat. Med., vol. 8, no. 1, pp. 51–56, 2010, doi: 10.1016/S1875-5364(10)60006-4.Google ScholarCross Ref
- X. Huo, F. Lu, L. Qiao, G. Li, and Y. Zhang, “A component formula of Chinese medicine for hypercholesterolemia based on virtual screening and biology network,” Evidence-based Complement. Altern. Med., vol. 2018, 2018, doi: 10.1155/2018/1854972.Google ScholarCross Ref
- R. Marahatha , “Potential natural inhibitors of xanthine oxidase and HMG-CoA reductase in cholesterol regulation: in silico analysis,” BMC Complement. Med. Ther., vol. 21, no. 1, pp. 1–11, 2021, doi: 10.1186/s12906-020-03162-5.Google ScholarCross Ref
- A. A. Tapiory, K. O. Pertiwi, K. Fadilla, D. Reyhanditya, and F. Fatchiyah, “JSMARTech CoA Reductase Inhibitor Complexes,” J. Smart Bioprospecting Technol., vol. 1, no. 2, pp. 5–9, 2020.Google Scholar
- Q. Y. Zhang , “Structure-based rational quest for potential novel inhibitors of human HMG-CoA reductase by combining CoMFA 3D QSAR modeling and virtual screening,” J. Comb. Chem., vol. 9, no. 1, pp. 131–138, 2007, doi: 10.1021/cc060101e.Google ScholarCross Ref
- O. Hermansyah, A. Bustamam, and A. Yanuar, “Virtual screening of dipeptidyl peptidase-4 inhibitors using quantitative structure–activity relationship-based artificial intelligence and molecular docking of hit compounds,” Comput. Biol. Chem., vol. 95, Dec. 2021, doi: 10.1016/j.compbiolchem.2021.107597.Google ScholarDigital Library
- S. Beisken, T. Meinl, B. Wiswedel, L. F. De Figueiredo, and M. Berthold, “KNIME-CDK: Workflow-driven cheminformatics,” BMC Informatics, vol. 14, no. 257, pp. 2–5, 2013, [Online]. Available: http://www.biomedcentral.com/1471-2105/14/257Google Scholar
- G. Falcón-Cano, C. Molina, and M. Á. Cabrera-Pérez, “ADME Prediction with KNIME: Development and Validation of a Publicly Available Workflow for the Prediction of Human Oral Bioavailability,” J. Chem. Inf. Model., vol. 60, no. 6, pp. 2660–2667, Jun. 2020, doi: 10.1021/acs.jcim.0c00019.Google ScholarCross Ref
- N. S. H. N. Moorthy and V. Poongavanam, “The KNIME based classification models for yellow fever virus inhibition,” RSC Adv., vol. 5, no. 19, pp. 14663–14669, 2015, doi: 10.1039/c4ra15317k.Google ScholarCross Ref
- S. Kausar and A. O. Falcao, “An automated framework for QSAR model building,” J. Cheminform., vol. 10, no. 1, pp. 1–23, 2018, doi: 10.1186/s13321-017-0256-5.Google ScholarCross Ref
- D. Sydow, M. Wichmann, J. Rodríguez-Guerra, D. Goldmann, G. Landrum, and A. Volkamer, “TeachOpenCADD-KNIME: A Teaching Platform for Computer-Aided Drug Design Using KNIME Workflows,” 2019, doi: 10.5281/zenodo.3475086.Google Scholar
- K. Roy, S. Kar, and R. N. Das, A Primer on QSAR/QSPR Modeling: Fundamental Concepts (Springer Briefs in Molecular Sciences). 2015. [Online]. Available: http://link.springer.com/10.1007/978-3-319-17281-1Google ScholarCross Ref
- P. Gramatica, On the development and validation of QSAR models, vol. 930. 2013. doi: 10.1007/978-1-62703-059-5_21.Google ScholarCross Ref
- T. O. Ayodele, “Types of Machine Learning Algorithms,” in New Advances in Machine Learning, 1st ed., Y. Zhang, Ed. Rijeke: InTech, 2010, pp. 19–48. [Online]. Available: http://www.intechopen.com/books/new-advances-in-machine-learning/types-of-machine-learning-algorithmsGoogle Scholar
- V. Svetnik, A. Liaw, C. Tong, J. Christopher Culberson, R. P. Sheridan, and B. P. Feuston, “Random Forest: A Classification and Regression Tool for Compound Classification and QSAR Modeling,” J. Chem. Inf. Comput. Sci., vol. 43, no. 6, pp. 1947–1958, 2003, doi: 10.1021/ci034160g.Google ScholarCross Ref
- X. Wang, X. Liu, W. Pedrycz, and L. Zhang, “Fuzzy rule based decision trees,” Pattern Recognit., vol. 48, no. 1, pp. 50–59, 2015, doi: 10.1016/j.patcog.2014.08.001.Google ScholarDigital Library
- R. Veerasamy, H. Rajak, A. Jain, S. Sivadasan, C. P. Varghese, and R. K. Agrawal, “Validation of QSAR Models - Strategies and Importance,” Int. J. Drug Des. Disocovery, vol. 2, no. 3, pp. 511–519, 2011.Google Scholar
- W. Sai, G. B. Chai, and N. Srikanth, “Fatigue Life Prediction of GLARE Composites Using Regression Tree Ensemble-Based Machine Learning Model,” Adv. Theory Simulations, vol. 3, no. 6, pp. 1–11, 2020, doi: 10.1002/adts.202000048.Google ScholarCross Ref
- A. C. Dweck and T. Meadowsy, “Tamanu (Calophyllum inophyllum) - the Afrikan, Asian, Polynesian and Pacific Panacea,” Int. J. Cosmet. Sci., vol. 24, no. 160, pp. 1–8, 2002.Google Scholar
- J. B. Friday and D. Okano, “Calophyllum inophyllum (kamani) Clusiaceae (syn. Guttiferae) (mangosteen family) Species Profiles for Pacific Island Agroforestry www.traditionaltree.org,” Doc-Developpement-Durable.Org, no. April, 2006, [Online]. Available: www.traditionaltree.orgGoogle Scholar
- H. C. Ong, T. M. I. Mahlia, H. H. Masjuki, and R. S. Norhasyima, “Comparison of palm oil, Jatropha curcas and Calophyllum inophyllum for biodiesel: A review,” Renew. Sustain. Energy Rev., vol. 15, no. 8, pp. 3501–3515, 2011, doi: 10.1016/j.rser.2011.05.005.Google ScholarCross Ref
- B. K. Venkanna and C. Venkataramana Reddy, “Biodiesel production and optimization from Calophyllum inophyllum linn oil (honne oil) - A three stage method,” Bioresour. Technol., vol. 100, no. 21, pp. 5122–5125, 2009, doi: 10.1016/j.biortech.2009.05.023.Google ScholarCross Ref
- M. C. Yimdjo, A. G. Azebaze, A. E. Nkengfack, A. M. Meyer, B. Bodo, and Z. T. Fomum, “Antimicrobial and cytotoxic agents from Calophyllum inophyllum,” Phytochemistry, vol. 65, no. 20, pp. 2789–2795, 2004, doi: 10.1016/j.phytochem.2004.08.024.Google ScholarCross Ref
Index Terms
- Virtual Screening of HMG-CoA reductase inhibitors of West Bali National Park natural compounds database using machine learning
Recommendations
Structure-based virtual screening of influenza virus RNA polymerase inhibitors from natural compounds: Molecular dynamics simulation and MM-GBSA calculation
Graphical abstractDisplay Omitted
Highlights- Structure-based virtual screening was performed to discover influenza virus polymerase inhibitors.
AbstractThe resistances of matrix protein 2 (M2) protein inhibitors and neuraminidase inhibitors for influenza virus have attracted much attention and there is an urgent need for new drug. The antiviral drugs that selectively act on RNA ...
Virtual screening of B-Raf kinase inhibitors
Display Omitted A combined virtual screening of B-Raf inhibitors was performed.Five of six hit compounds show good biological activities (IC50<50M).Five structurally diverse compounds are expected to develop novel B-Raf inhibitors. B-Raf kinase has been ...
Pharmacophore modeling, virtual screening and molecular docking of ATPase inhibitors of HSP70
Display Omitted Heat shock protein 70 is an effective anticancer target as it influences many signaling pathways.Key pharmacophore features required for ATPase inhibitory activity of HSP70 were identified by ligand based pharmacophore model.The ...
Comments